Elevated levels of plasma alpha1-antitrypsin (AAT) correlate with a poor prognosis of various cancers. Herein, we investigated effects of exogenous AAT on non-small lung cancer cell lines with high (H1975) and very low (H661) baseline expression of SERPINA1 gene encoding AAT protein. Comparison of cells grown for 3 weeks in a regular medium versus medium supplemented with 2 mg/ml of AAT revealed that in the presence of AAT cells acquire better proliferative properties, resistance to staurosporine (STS)-induced apoptosis, and show higher expression of CLU, a pro-tumorigenic gene coding clusterin protein. Similarly, the co-administration of STS with AAT or addition of AAT to the cells pre-treated with STS abrogated effects of STS in both cell lines. Following experiments with H1975 cells have shown that AAT blocks critical steps in STS-induced cell death: inhibition of AKT/MAPK pathways, and activation of caspase 3 and autophagy. AAT does not inhibit apoptosis-triggered by chloroquine (inhibitor of autophagy) or streptonigrin (inducer of p53 pathway). The anti-apoptotic effects of AAT were unaffected by lipopolysaccharide (LPS). However, AAT induced TLR4 levels and enhanced LPS effects on the production of IL-6, a tumor-promoting cytokine. Our data provide further evidence that AAT plays a significant role in the tumorigenesis. In recent years, an importance of the inflammation in cancer progression became more recognised 1. In both early and advanced stages of cancer, the development and maintenance of a systemic inflammation confer poorer outcome 2. Repeated studies show that neutrophil, lymphocyte and platelet counts, and acute phase proteins, such as C-reactive protein and albumin and their combinations, have a prognostic value 3-5. Besides, the major hallmark of human cancers is the resistance to apoptosis and treatments, since most current anticancer therapies, including chemotherapy, radio-and immunotherapy, primarily act by activating cell death pathways 6. Different research groups reported that acute phase proteins interfere with apoptosis induction. For example, α1-acid glycoprotein expresses a direct anti-apoptotic mode on tumor necrosis factor (TNF)-α-induced apoptosis 7. The C-reactive protein enhances secretion of interleukin 6 (IL-6) and, synergized with IL-6, protects cancer cells from chemotherapy-induced apoptosis 8,9. There are observations that certain members of serine protease inhibitor (serpin) superfamily, such as plasminogen activator inhibitor-1, are also associated with poor outcome in several types of cancer 10. Alpha1-antitrypsin (AAT) is another acute phase protein and an archetype member of serpin superfamily, well recognized for its role as a serine protease inhibitor, but also known as an inhibitor of caspase 3, anti-apoptotic and immunomodulatory protein in vitro and in vivo 11. Various studies provide evidence that higher AAT levels are associated with cancer and a poor prognosis 12,13. AAT seems to be directly involved in the distant metastasis of various cancer types, including...